4DMedical Financial Statements From 2010 to 2025
| FDMDF Stock | USD 2.35 0.50 27.03% |
Check 4DMedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 4DMedical's main balance sheet or income statement drivers, such as , as well as many indicators such as . 4DMedical financial statements analysis is a perfect complement when working with 4DMedical Valuation or Volatility modules.
4DMedical |
4DMedical Limited Company Operating Margin Analysis
4DMedical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current 4DMedical Operating Margin | (34.86) % |
Most of 4DMedical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 4DMedical Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, 4DMedical Limited has an Operating Margin of -34.8578%. This indicator is about the same for the Healthcare average (which is currently at -35.08) sector and 11.33% lower than that of the Medical Devices industry. The operating margin for all United States stocks is notably higher than that of the company.
4DMedical Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 4DMedical's current stock value. Our valuation model uses many indicators to compare 4DMedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 4DMedical competition to find correlations between indicators driving 4DMedical's intrinsic value. More Info.4DMedical Limited is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 4DMedical's earnings, one of the primary drivers of an investment's value.About 4DMedical Financial Statements
4DMedical stakeholders use historical fundamental indicators, such as 4DMedical's revenue or net income, to determine how well the company is positioned to perform in the future. Although 4DMedical investors may analyze each financial statement separately, they are all interrelated. For example, changes in 4DMedical's assets and liabilities are reflected in the revenues and expenses on 4DMedical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 4DMedical Limited. Please read more on our technical analysis and fundamental analysis pages.
4DMedical Limited operates as a medical technology company in Australia and the United States. The company was incorporated in 2012 and is based in Carlton, Australia. 4Dmedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 95 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in 4DMedical Pink Sheet
4DMedical financial ratios help investors to determine whether 4DMedical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4DMedical with respect to the benefits of owning 4DMedical security.